"Z\u00E1kladem l\u00E9\u010Dby bipol\u00E1rn\u00ED afektivn\u00ED poruchy (BAP) je pod\u00E1v\u00E1n\u00ED thymoprofylaktika (stabiliz\u00E1toru n\u00E1lady) v ka\u017Ed\u00E9 f\u00E1zi onemocn\u011Bn\u00ED. V posledn\u00ED dob\u011B p\u0159ib\u00FDvaj\u00ED d\u016Fkazy o \u00FA\u010Dinnosti antipsychotik druh\u00E9 generace v jednotliv\u00FDch f\u00E1z\u00EDch BAP, tato antipsychotika jsou v klinick\u00E9 praxi st\u00E1le \u010Dast\u011Bji pou\u017E\u00EDv\u00E1na. D\u016Fvodem je vedle jejich \u00FA\u010Dinnosti tak\u00E9 rychlej\u0161\u00ED n\u00E1stup \u00FA\u010Dinku a odli\u0161n\u00E9 spektrum vedlej\u0161\u00EDch ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F ve srovn\u00E1n\u00ED s %22klasick\u00FDmi%22 thymoprofylaktiky lithiem, valpro\u00E1tem a karbamazepinem. Sd\u011Blen\u00ED shrnuje sou\u010Dasn\u00E9 poznatky o \u00FA\u010Dinnosti, sn\u00E1\u0161enlivosti a bezpe\u010Dnosti l\u00E9\u010Div u\u017E\u00EDvan\u00FDch v l\u00E9\u010Db\u011B BAP." . . "5"^^ . . "6" . "Z\u00E1kladem l\u00E9\u010Dby bipol\u00E1rn\u00ED afektivn\u00ED poruchy (BAP) je pod\u00E1v\u00E1n\u00ED thymoprofylaktika (stabiliz\u00E1toru n\u00E1lady) v ka\u017Ed\u00E9 f\u00E1zi onemocn\u011Bn\u00ED. V posledn\u00ED dob\u011B p\u0159ib\u00FDvaj\u00ED d\u016Fkazy o \u00FA\u010Dinnosti antipsychotik druh\u00E9 generace v jednotliv\u00FDch f\u00E1z\u00EDch BAP, tato antipsychotika jsou v klinick\u00E9 praxi st\u00E1le \u010Dast\u011Bji pou\u017E\u00EDv\u00E1na. D\u016Fvodem je vedle jejich \u00FA\u010Dinnosti tak\u00E9 rychlej\u0161\u00ED n\u00E1stup \u00FA\u010Dinku a odli\u0161n\u00E9 spektrum vedlej\u0161\u00EDch ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F ve srovn\u00E1n\u00ED s %22klasick\u00FDmi%22 thymoprofylaktiky lithiem, valpro\u00E1tem a karbamazepinem. Sd\u011Blen\u00ED shrnuje sou\u010Dasn\u00E9 poznatky o \u00FA\u010Dinnosti, sn\u00E1\u0161enlivosti a bezpe\u010Dnosti l\u00E9\u010Div u\u017E\u00EDvan\u00FDch v l\u00E9\u010Db\u011B BAP."@cs . "V" . "2"^^ . "Second generation antipsychotics and mood stabilizers in the treatment of bipolar disorder: efficacy and safety."@en . . "21" . "Antipsychotika druh\u00E9 generace a thymoprofylaktika v l\u00E9\u010Db\u011B bipol\u00E1rn\u00ED poruchy: \u00FA\u010Dinnost a bezpe\u010Dnost" . "Antipsychotika druh\u00E9 generace a thymoprofylaktika v l\u00E9\u010Db\u011B bipol\u00E1rn\u00ED poruchy: \u00FA\u010Dinnost a bezpe\u010Dnost"@cs . "Second generation antipsychotics and mood stabilizers in the treatment of bipolar disorder: efficacy and safety."@en . "2"^^ . . . . "RIV/00179906:_____/11:10108493!RIV12-MZ0-00179906" . . "tolerance; efficacy; second generation antipsychotics; mood stabilizers; bipolar affective disorder"@en . . . "Antipsychotika druh\u00E9 generace a thymoprofylaktika v l\u00E9\u010Db\u011B bipol\u00E1rn\u00ED poruchy: \u00FA\u010Dinnost a bezpe\u010Dnost" . . "186500" . . . "RIV/00179906:_____/11:10108493" . . "The cornerstone of the treatment of bipolar affective disorder (BAD) of any stage is mood stabilizers. Recently, a growing body of evidence has been accumulated of the beneficial effect of second generation antipsychotics in various stages of BAD and these antipsychotics have been increasingly used in clinical practice. The reasons are, apart from their efficacy, a more rapid onset of action and a different range of adverse effects in comparison with the classical mood stabilizers, such as lithium, valproate and carbamezapine. This communication summarizes the current knowledge on the efficacy, tolerance, and safety of the drugs used in BAD treatment."@en . . . "Homolkov\u00E1, Barbora" . "Remedia" . "Antipsychotika druh\u00E9 generace a thymoprofylaktika v l\u00E9\u010Db\u011B bipol\u00E1rn\u00ED poruchy: \u00FA\u010Dinnost a bezpe\u010Dnost"@cs . . "CZ - \u010Cesk\u00E1 republika" . "[96CAD5353072]" . . "0862-8947" . "Masopust, Ji\u0159\u00ED" . .